Clinical Report: AGA strengthens payor ties to ease admin burden
Overview
The American Gastroenterological Association (AGA) is actively engaging with national insurers to address the administrative burdens faced by gastroenterology practices, particularly regarding prior authorization and drug formularies.
Background
The increasing administrative demands from payors, including prior authorization requirements, have created significant challenges in gastroenterology, leading to delays in patient care. The AGA is advocating for reforms to alleviate these burdens.
Data Highlights
No numerical or trial data was provided in the source material.
Key Findings
- AGA has initiated discussions with major payors since fall 2024 to streamline prior authorizations and improve coding education.
- The AGA launched the Payor Resource Center in August 2025 to assist members in contesting payor denials, starting with IBD.
- Collaboration with payors has led to improved communication regarding coverage criteria and clinical guidelines.
- AGA is partnering with Latica to generate real-world evidence on guideline impact and patient outcomes.
- Concerns were raised by AGA regarding the Care Gap Program and its potential impact on the physician-patient relationship.
Clinical Implications
Healthcare professionals should be aware of the ongoing efforts by AGA to reduce administrative burdens.
Conclusion
AGA's proactive engagement with payors represents a significant step towards alleviating administrative challenges in gastroenterology. Continued collaboration is essential for improving patient access to care.
Related Resources & Content
- GI and Hepatology News, 2025 -- AGA strengthens payor ties to ease admin burden
- conexiant, 2025 -- AGA Seeks to Make IBD Care Affordable and Equitable With New 12-Point Plan
- The New Gastroenterologist, 2025 -- AGA Advocacy Agenda Influenced by Member Priorities
- The New Gastroenterologist, 2025 -- Upcoming Reductions in Physician Compensation
- The New Gastroenterologist — AGA Advocates, Including Patients and Physicians, Lobby for Reform of Prior Authorization on Capitol Hill
- GI and Hepatology News - AGA strengthens payor ties to ease admin burden
- Living guideline for pharmacological management of moderate-to-severe ulcerative colitis – American Gastroenterological Association
- Frontiers | Efficacy and safety of IL-23 inhibitors in the treatment of moderate to severe ulcerative colitis: a meta-analysis based on randomized controlled trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
